可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Laakso M.Heart in diabetes: a microvascular disease[J].Diabetes Care,2011,34(Suppl 2):S145-S149.
[2]Giacco F,Brownlee M.Oxidative stress and diabetic complications[J].Circ Res,2010,107(9):1058-1070.
[3]Duncan JG.Mitochondrial dysfunction in diabetic cardiomyopathy[J].Biochim Biophys Acta,2011,1813(7):1351-1359.
[4]Aneja A,Tang WH,Bansilal S,et al.Diabetic cardiomyopathy:in-sights into pathogenesis,diagnostic challenges, and therapeutic options[J].Am J Med,2008,121(9):748-757.
[5]Ma H,Li SY,Xu P,et al.Advanced glycation endproduct(AGE)accumulation and AGE receptor(RAGE)upregulation contribute to the onset of diabetic cardiomyopathy[J].J Cell Mol Med,2009,13(8B):1751-1764.
[6]Lorenzo O,Picatoste B,Ares-Carrasco S,et al.Potential role of nuclear factor κB in diabetic cardiomyopathy[J].Mediators Inflamm,2011,2011:652097.
[7]黄 海,宋成运,杜大勇,等.糖尿病性心肌病变患者胰岛素强化治疗前后氧化应激水平的变化[J].心脏杂志,2012,24(5):606-608.